425: Strive Board Member Posts on X Regarding Semler Merger

Strive, Inc. board member Ben Werkman posted on X.com regarding the proposed business combination with Semler Scientific, Inc., accompanied by extensive cautionary statements.

Summary

• Strive, Inc. board member Ben Werkman posted on X.com on September 23, 2025, concerning the proposed business combination with Semler Scientific, Inc.
• The communication is a Form 425 filing, deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934.
• The filing includes a cautionary statement regarding forward-looking statements related to the proposed transaction, its strategic and financial benefits, timing, and integration.
• Investors are urged to read the Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, before making any voting or investment decisions.
• Strive intends to issue Class A common stock in connection with the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a procedural communication about a proposed merger, heavily weighted with cautionary statements and risks, balancing the potential benefits with significant uncertainties.

Positives

• The proposed transaction is expected to yield strategic and financial benefits, including anticipated cost savings and strategic gains for the combined company.

Negatives

• The filing highlights numerous risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Potential for the proposed transaction to be more difficult, time-consuming, or costly than expected.
• Diversion of management's attention from ongoing business operations.
• Potential for dilution caused by Strive's issuance of additional shares of Class A common stock.
• Possible adverse reactions from customers or changes in business/employee relationships.

Risks

• Occurrence of any event, change, or circumstance that could lead to termination of the merger agreement.
• The proposed transaction may not close when expected or at all due to unfulfilled conditions.
• Outcome of any legal proceedings against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks related to Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors affecting future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed business combination, including cost savings and successful integration. However, these outcomes are subject to significant risks and uncertainties, and there is no assurance that actual results will align with projected future results.

Management Comments

• The following communication was posted on X.com by Ben Werkman, Board Member of Strive, Inc. (Strive), on September 23, 2025, in connection with Strives proposed business combination with Semler Scientific, Inc. (Semler Scientific).

Industry Context

The filing highlights risks associated with "Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets," indicating that the combined entity or at least one of the companies is involved in or plans to adopt digital asset strategies. This aligns with a growing trend of corporations exploring or integrating digital assets into their financial operations.

Corporate Governance

Legal Proceedings

• The filing mentions "the outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company" as a risk factor, but does not detail any current legal proceedings.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons will be set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders. This filing does not detail any specific related party transactions.

Stakeholder Impact

• Shareholders: Potential dilution for Strive shareholders due to the issuance of additional Class A common stock. Semler Scientific stockholders will vote on the proposed transaction.
• Customers: Potential for adverse reactions from Strive's or Semler Scientific's customers.
• Employees: Potential for changes to employee relationships.
• Management: Diversion of management's attention from ongoing business operations.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive, Semler Scientific, merger, business combination, acquisition, SEC filing, Form 425, Bitcoin treasury, digital assets, corporate governance, risk management, financial reporting